relapsed and refractory Hodgkin’s lymphoma

June 11, 2019

Tyvyt Effective, Safe in Previously Treated Patients with Hodgkin’s Lymphoma, Phase 2 Trial Shows

News

Treatment with Tyvyt (sintilimab injection) was found safe and eased the tumor burden or led to cancer disappearance in nearly 3 out of 10 patients with relapsed or refractory classical ... Read more

September 24, 2018

Adcetris May Increase Risk of Lung Toxicity in Younger Hodgkin’s Lymphoma Patients, Study Suggests

News

Adcetris (brentuximab vedotin) treatment may increase the chances of lung toxicity in children and young adults with relapsed or refractory Hodgkin’s lymphoma, a small retrospective study suggests. The study, “Pulmonary ... Read more